Who is sponsoring NCT04306432?

NCT04306432 is sponsored by University of Aarhus.

What drugs are being tested in NCT04306432?

Interventions in NCT04306432: Cognitive tests and Patient Reported Outcomes.

What condition does NCT04306432 study?

NCT04306432 studies Primary Brain Tumour, Radiation Toxicity, Cognitive Impairment.

Is NCT04306432 still recruiting?

NCT04306432 is currently recruiting now. Last updated 2 December 2021.

Last reviewed 2021-12-02 · How we verify

NCT04306432

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cognitive Function After Radiation Therapy for Primary Brain Tumours

Recruiting now Last updated 2 December 2021

What this trial tests

trial testing Cognitive tests and Patient Reported Outcomes in Primary Brain Tumour in 300 participants. Currently enrolling.

Timeline

3 January 2019

Primary endpoint
31 March 2034

31 March 2034

Quick facts

Lead sponsor	University of Aarhus
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	300
Start date	3 January 2019
Primary completion	31 March 2034
Estimated completion	31 March 2034
Sites	5 locations across Denmark

Drugs / interventions tested

Cognitive tests and Patient Reported Outcomes

Conditions studied

Primary Brain Tumour — all drugs for Primary Brain Tumour →
Radiation Toxicity — all drugs for Radiation Toxicity →
Cognitive Impairment — all drugs for Cognitive Impairment →

Sponsor

University of Aarhus

Who can join

Adults 18 to 100, any sex, with Primary Brain Tumour or Radiation Toxicity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will assess cognitive function in patients with a primary brain tumour treated with radiation therapy (RT) to generate radio-sensitivity and volume effect parameters for the development of cognitive dysfunction. All types of brain tumours apart from glioblastoma will be included.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Primary Brain Tumour

Currently open trials in the same condition.

NCT07426848 — OT SMILE: Occupational Therapy Group Intervention for Primary Brain Tumour Patients · NA · recruiting

Other University of Aarhus trials

Trials by the same sponsor.

NCT07209540 — European LUpuS Inception-Cohort Developing initiATivE · not yet recruiting
NCT07317401 — Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Post-Viral Myalgic Encephalo · NA · not yet recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
NCT07528339 — Prospective RegIstry for Oncologic Reirradiation (PRIOR-DK) · not yet recruiting
NCT07451028 — Effect of an Oral Neuromuscular Training Device on Dysphagia · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04306432 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Aarhus
Last refreshed: 2 December 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04306432.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing